通化东宝：胰岛素周制剂目前处于临床前研究阶段

Core Viewpoint - Tonghua Dongbao (600867) is currently in the preclinical research phase for its insulin weekly formulation, with future research progress to be disclosed according to relevant regulations and requirements [1] Group 1 - The company has a strategic focus on developing insulin weekly formulations [1] - The research is currently at the preclinical stage, indicating ongoing development efforts [1] - The company will provide updates on research progress through regular reports and announcements [1]